Diabetes and Kidney Disease 2022
DOI: 10.1007/978-3-030-86020-2_21
|View full text |Cite
|
Sign up to set email alerts
|

Glycemic Control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 68 publications
0
0
0
Order By: Relevance
“…In renal failure, the oral agents that can be used therefore include the insulin secretagogues repaglinide and nateglinide and the thiazolidinediones (rosiglitazone and pioglitazone) with caution. Insulin also can be used safely in ESRD (Krikorian and Calimag, 2022).…”
Section: -Homeostasis Model Assessment Insulin Sensitivity (Homa2%ir)...mentioning
confidence: 99%
“…In renal failure, the oral agents that can be used therefore include the insulin secretagogues repaglinide and nateglinide and the thiazolidinediones (rosiglitazone and pioglitazone) with caution. Insulin also can be used safely in ESRD (Krikorian and Calimag, 2022).…”
Section: -Homeostasis Model Assessment Insulin Sensitivity (Homa2%ir)...mentioning
confidence: 99%